Social Capital Suvretta Holdings Corp. I

Social Capital Suvretta Holdings Corp. I (Nasdaq: DNAA) was a blank-check company sponsored by Social Capital Suvretta, a joint venture between Chamath Palihapitiya's Social Capital and healthcare-focused investment manager Suvretta Capital Management. The SPAC completed its initial public offering in 2021, targeting opportunities in the healthcare and life sciences sector. In July 2022, it filed a definitive merger proxy — form DEFM14A — with the SEC in connection with its proposed business combination with ProKidney Corp, a clinical-stage regenerative medicine company developing autologous cell therapy for chronic kidney disease. The filing advanced the transaction toward a shareholder vote and de-SPAC closing. Sign up on SpacDesk for complete filing history, deal timelines, and analytics across the SPAC universe.